GlaxoSmithKline PLC, which is facing various federal and congressional investigations, has hired Daniel Troy, a former chief counsel for the U.S. Food and Drug Administration, as its new general counsel.
Mr. Troy, currently a partner at the Washington law firm Sidley Austin LLP, represents pharmaceutical companies and trade associations that deal ...
Email
Printer Friendly
Order Reprints
